Radimer KL, Subar AF, Thompson FE. Nonvitamin, nonmineral dietary supplements: issues and findings from
NHANES III. J Am Diet Assoc.2000;100:447-454.
Astrup A, Breum L, Toubro S, Hein P, Quaade F. The effect and safety of an ephedrine/caffeine compound compared to
ephedrine, caffeine, and placebo in obese subjects on an energy restricted
diet: a double blind trial. Int J Obes Relat Metab Disord.1992;16:269-277.
Astrup A, Toubro S, Cannon S, Hein P, Madsen J. Thermogenic synergism between ephedrine and caffeine in healthy volunteers:
a double-blind, placebo-controlled study. Metabolism.1991;40:323-329.
Allison DB, Fontaine KR, Heshka S, Mentore JL, Heymsfield SB. Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr.2001;41:1-28.
Food and Drug Administration. Dietary supplements containing ephedrine alkaloids. 62 Federal Register.30 677-37 024 (1997).
Food and Drug Administration. Dietary supplements containing ephedrine alkaloids; withdrawal in part. 65 Federal Register.17 477 (2000).
Williams DM. Phenylpropanolamine hydrochloride. Am Pharm.1990;NS30(10):47-50.
Greenway F, Herber D, Raum W, Herber D, Morales S. Double-blind, randomized, placebo-controlled clinical trials with non-prescription
medications for the treatment of obesity. Obes Res.1999;7:370-378.
Pentel P. Toxicity of over-the-counter stimulants. JAMA.1984;252:1898-1903.
Lake RC, Gallant S, Masson E, Miller P. Adverse drug effects attributed to phenylpropanolamine: a review of
142 case reports. Am J Med.1990;89:195-208.
Bradley JG. Nonprescription drugs and hypertension: which ones affect blood pressure. Postgrad Med.1991;89:195-7, 201-2. Review.
Kernan WN, Viscoli CM, Brass LM.
et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med.2000;343:1826-1832.
Nelson DE, Holtzman D, Waller M, Leutzinger CL, Condon K. Objectives and design of the Behavioral Risk Factor Surveillance System. In: Proceedings of the Section on Survey Methods, American Statistical
Association National Meeting; August 9-13, 1998; Dallas, Tex.
Dietary Guidelines Advisory Committee. Report of the Dietary Guidelines Advisory Committee
on the Dietary Guidelines for Americans, 1995. Washington, DC: US Dept of Agriculture, Agricultural Research Service;
US Department of Health and Human Services. Third National Health and Nutrition Examination Survey,
1988-1994, NHANES III Examination Data File [Public Use Data File Documentation
No. 76200]. Hyattsville, Md: Centers for Disease Control and Prevention; 1996.
Shah BV, Barnwell BG, Bieler GS. SUDAAN Users' Manual, Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
Leavy AS, Heaton AW. Weight control practices of US adults trying to lose weight. Ann Intern Med.1993;119(7 pt 2):661-666.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated
with dietary supplements containing ephedra alkaloids. N Engl J Med.2000;343:1833-1838.
Food and Drug Administration. Dietary Supplements Containing Ephedrine Alkaloids. Rockville, Md: Food and Drug Administration; 2000.
Dietary Supplement Health and Education Act of 1994. US Pub L No. 102-417, 108 Stat 4325. October 25, 1994.
Lewis CJ. Regulatory environment for dietary supplements and botanicals targeted
to weight loss. Crit Rev Food Sci Nutr.2001;41:43-44.
Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm.2000;57:963-969.
Eisenberg DM, Davis RB, Ettner SL.
et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA.1998;280:1569-1575.
Insel PA. Beta-adrenergic receptors in pathophysiologic states and in clinical
medicine. In: Perkins JP, Clifton NJ, eds. The Beta-Adrenergic
Receptors. Totowa, NJ: The Humana Press Inc; 1991:295-343.
Hankin J. Keeping up with the increasing popularity of nonvitamin, nonmineral
supplements. J Am Diet Assoc.2000;100:419-420.
Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States 1991-1998. JAMA.1999;282:1519-1522.